BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31761712)

  • 1. Evaluating Novel PET-CT Functional Parameters TLG and TMTV in Differentiating Low-grade Versus Grade 3A Follicular Lymphoma.
    Major A; Hammes A; Schmidt MQ; Morgan R; Abbott D; Kamdar M
    Clin Lymphoma Myeloma Leuk; 2020 Jan; 20(1):39-46. PubMed ID: 31761712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline Total Metabolic Tumor Volume and Total Lesion Glycolysis Measured on 18F-FDG PET-CT Predict Outcomes in T-Cell Lymphoblastic Lymphoma.
    Feng X; Wen X; Li L; Sun Z; Li X; Zhang L; Wu J; Fu X; Wang X; Yu H; Ma X; Zhang X; Xie X; Han X; Zhang M
    Cancer Res Treat; 2021 Jul; 53(3):837-846. PubMed ID: 33285054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [
    Xu HQ; Song LJ; Ding CY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1690-1700. PubMed ID: 38071047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of Baseline and Interim Total Metabolic Tumor Volume and Total Lesion Glycolysis Measured on 18F-FDG PET-CT in Patients with Follicular Lymphoma.
    Liang JH; Zhang YP; Xia J; Ding CY; Wu W; Wang L; Cao L; Zhu HY; Fan L; Li TN; Li JY; Xu W
    Cancer Res Treat; 2019 Oct; 51(4):1479-1487. PubMed ID: 30913868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline [
    Yang Q; Luo Y; Zhang Y; Zhang W; Zhou D; Li F
    Eur Radiol; 2022 Aug; 32(8):5568-5576. PubMed ID: 35316362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of interim
    Sun N; Qiao W; Xing Y; Wang T; Zhao J
    Ann Hematol; 2023 Apr; 102(4):795-800. PubMed ID: 36806973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of baseline
    Zhou Y; Hong Z; Zhou M; Sang S; Zhang B; Li J; Li Q; Wu Y; Deng S
    J Med Imaging Radiat Oncol; 2020 Feb; 64(1):87-95. PubMed ID: 31880103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High baseline total lesion glycolysis predicts early progression of disease within 24 months in patients with high-tumor-burden follicular lymphoma.
    Kuroki W; Kitadate A; Ishiyama K; Kameoka Y; Takahashi N
    Int J Hematol; 2022 Nov; 116(5):712-722. PubMed ID: 35857194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Values of Baseline
    Zhou Y; Zhang X; Qin H; Zhao Z; Li J; Zhang B; Sang S; Wu Y; Deng S
    Biomed Res Int; 2020; 2020():9746716. PubMed ID: 32185229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting time to treatment in follicular lymphoma on watchful waiting using baseline metabolic tumour burden.
    Leccisotti L; Maccora D; Malafronte R; D'Alò F; Maiolo E; Annunziata S; Rufini V; Giordano A; Hohaus S
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):2783-2791. PubMed ID: 35779106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of baseline and end of chemotherapy
    Xiao Z; Mo Y; Long W; Li R; Li X; Wei Y; Fan W; Zhang X
    Leuk Lymphoma; 2021 Dec; 62(12):2873-2881. PubMed ID: 34165390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of prognosis and pathologic grade in follicular lymphoma using
    Li H; Wang M; Zhang Y; Hu F; Wang K; Wang C; Gao Z
    Front Oncol; 2022; 12():943151. PubMed ID: 35965552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic tumor burden on baseline
    Chen S; He K; Feng F; Wang S; Yin Y; Fu H; Wang H
    Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1830-1839. PubMed ID: 31187163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic tumor volume predicts outcome in patients with advanced stage follicular lymphoma from the RELEVANCE trial.
    Cottereau AS; Rebaud L; Trotman J; Feugier P; Nastoupil LJ; Bachy E; Flinn IW; Haioun C; Ysebaert L; Bartlett NL; Tilly H; Casasnovas O; Ricci R; Portugues C; Buvat I; Meignan M; Morschhauser F
    Ann Oncol; 2024 Jan; 35(1):130-137. PubMed ID: 37898239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of the combination of volume, massiveness and fragmentation parameters measured on baseline FDG pet in high-burden follicular lymphoma.
    Draye-Carbonnier S; Camus V; Becker S; Tonnelet D; Lévêque E; Zduniak A; Jardin F; Tilly H; Vera P; Decazes P
    Sci Rep; 2024 Apr; 14(1):8033. PubMed ID: 38580734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of
    Yang J; Yan J; Li J; Yang Z; Zhang H; Zhao Q; Xu W
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2022; 41(2):91-99. PubMed ID: 35292144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Value of Volume-Based Fluorine-18-Fluorodeoxyglucose PET/CT Parameters for Characterizing Thyroid Incidentaloma.
    Shi H; Yuan Z; Yuan Z; Yang C; Zhang J; Shou Y; Zhang W; Ping Z; Gao X; Liu S
    Korean J Radiol; 2018; 19(2):342-351. PubMed ID: 29520193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratumoral T cells have a differential impact on FDG-PET parameters in follicular lymphoma.
    Nath K; Law SC; Sabdia MB; Gunawardana J; de Long LM; Sester D; Shanavas M; Tsang H; Tobin JWD; Halliday SJ; Hernandez A; Cross D; Bird RJ; Jain S; Keane C; Talaulikar D; Trotman J; Law P; Gandhi MK
    Blood Adv; 2021 Jun; 5(12):2644-2649. PubMed ID: 34156439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A different perspective on PET/CT before treatment in patients with Hodgkin lymphoma: importance of volumetric and dissemination parameters.
    Aksu A; Küçüker KA; Solmaz Ş; Turgut B
    Ann Hematol; 2024 Mar; 103(3):813-822. PubMed ID: 37964021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Impact of Pretreatment 2-[
    Albano D; Dondi F; Mazzoletti A; Bellini P; Giubbini R; Bertagna F
    Medicina (Kaunas); 2021 May; 57(5):. PubMed ID: 34069203
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.